IRA & Medicare drug price negotiation
CMS Issues Final Rule on the Medicare Drug Price Negotiation Program and Medicare Prescription Drug Benefit Program
AMCP (Academy of Managed Care Pharmacy)Topic alignment 95
CMS Issues Final Rule on the Medicare Drug Price Negotiation Program and Medicare Prescription Drug Benefit Program spassin@amcp.org Fri, 11/06/2026 - 14:43 On November 5, 2026, the Centers for Medicare and Medicaid Services issued a final rule on the Medicare Drug Price Negotiation Program and Medicare Prescription Drug Benefit Program (Final Rule).The Final Rule codifies existing policies from guidance for the Negotiation Program into regulatory text.Policies being codified incl
Filed under
CMS finalizes rule to codify Medicare Drug Price Negotiation Program
AHATopic alignment 95
Most-Favored-Nation Drug Pricing Framework: How Manufacturer Agreements Affect Medicaid Best Price, Contracts, and Compliance
Frier LevittTopic alignment 90
How the Biosimilars Access and Affordability Act Redefines IRA Delays
The Center for BiosimilarsTopic alignment 92
Medicare Part D Premiums and Cost Sharing in 2027
KFFTopic alignment 88